SCHEMBL9249055

SCHEMBL9249055

N[C@@H](Cc1ccc(O)c(CP(=O)(O)O)c1)C(=O)O

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC7A5 Q01650 3/20 0.64
ALOX15 P16050 3/20 0.63
HSD17B10 Q99714 3/20 0.63
TDP1 Q9NUW8 2/20 0.63
KDM4E B2RXH2 1/20 0.63
USP2 O75604 1/20 0.63
EGFR P00533 1/20 0.63
LCK P06239 1/20 0.63
FYN P06241 1/20 0.63
ADORA3 P0DMS8 1/20 0.63
PTGS1 P23219 1/20 0.63
HTR2A P28223 1/20 0.63
PTGS2 P35354 1/20 0.63
RECQL P46063 1/20 0.63
HIF1A Q16665 1/20 0.63
MAPK1 P28482 2/20 0.58
PTPRC P08575 1/20 0.52
MEN1 O00255 2/20 0.48
CYP2C19 P33261 2/20 0.48
KMT2A Q03164 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Levodopa SCHEMBL31442655 0.82 SLC7A5 (0.87) SLC7A5ALOX15HSD17B10TDP1KDM4E
Levodopa SCHEMBL9108304 0.82 SLC7A5 (0.87) SLC7A5ALOX15HSD17B10TDP1KDM4E
SCHEMBL1248325 0.82 SLC7A5 (0.71) SLC7A5ALOX15HSD17B10TDP1KDM4E
Levodopa SCHEMBL17685886 0.82 SLC7A5 (0.87) SLC7A5ALOX15HSD17B10TDP1KDM4E
Levodopa SCHEMBL13719874 0.82 SLC7A5 (0.87) SLC7A5ALOX15HSD17B10TDP1KDM4E
SCHEMBL5321753 0.82 SLC7A5 (0.71) SLC7A5ALOX15HSD17B10TDP1KDM4E
SCHEMBL29585153 0.82 SLC7A5 (0.71) SLC7A5ALOX15HSD17B10TDP1KDM4E
SCHEMBL20912657 0.82 SLC7A5 (0.71) SLC7A5ALOX15HSD17B10TDP1KDM4E
SCHEMBL20912658 0.82 SLC7A5 (0.71) SLC7A5ALOX15HSD17B10TDP1KDM4E
Levodopa SCHEMBL29653523 0.82 SLC7A5 (0.87) SLC7A5ALOX15HSD17B10TDP1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0418375-B1 PHOSPHORYLATED DERIVATIVES OF L-DOPA AND COMPOSITIONS PAWELEK JOHN M (US) 1995-03-22 EP disclosed
US-5100654-A Treatment of pigmentation disorders, suntan lotion YALE UNIVERSITY (US) 1992-03-31 US disclosed
EP-0418375-A4 PHOSPHORYLATED DERIVATIVES OF L-DOPA AND COMPOSITIONS AND METHODS FOR INCREASING THE MELANIN CONTENT IN MAMMALIAN SKIN HAIR 1991-09-11 EP disclosed
EP-0418375-A1 PHOSPHORYLATED DERIVATIVES OF L-DOPA AND COMPOSITIONS AND METHODS FOR INCREASING THE MELANIN CONTENT IN MAMMALIAN SKIN HAIR. PAWELEK JOHN M (US) 1991-03-27 EP disclosed
WO-1990012016-A1 PHOSPHORYLATED DERIVATIVES OF L-DOPA AND COMPOSITIONS AND METHODS FOR INCREASING THE MELANIN CONTENT IN MAMMALIAN SKIN HAIR PAWELEK JOHN M (US) 1990-10-18 WO disclosed